V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218807 | 20178425 | 1.82 | 63.7 | null | 2016-10-12 | 2016-10-12 | ECX | N | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100772723 |
| 20218808 | 20178426 | 1.8 | 58 | Palliative (P) | 2021-10-21 | 2021-10-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100172881 |
| 20218868 | 20178427 | 1.73 | 82.3 | Palliative (P) | 2020-07-29 | 2020-08-06 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101861290 |
| 20218881 | 20178428 | 1.7 | 71.9 | null | 2021-03-18 | 2021-04-10 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101696898 |
| 20218934 | 20178429 | 1.65 | 71 | Neo-adjuvant (N) | 2021-09-19 | 2022-02-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101756647 |
| 20218942 | 20178430 | 1.84 | 66.4 | Palliative (P) | 2019-09-17 | 2019-10-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100197295 |
| 20218978 | 20178431 | 1.73 | 64.8 | Adjuvant (A) | 2019-12-24 | 2020-01-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100886759 |
| 20219015 | 20178432 | 1.46 | 79.4 | Palliative (P) | 2018-09-04 | 2018-09-17 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100687325 |
| 20219051 | 20178433 | 1.73 | 41.6 | null | 2018-07-27 | 2018-10-22 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101650398 |
| 20219081 | 20178434 | 1.86 | 83 | Palliative (P) | 2018-07-24 | 2018-10-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100398303 |
| 20219163 | 20178435 | 1.68 | 65 | null | 2019-11-24 | 2019-12-16 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101715870 |
| 20219191 | 20178436 | 1.8 | 38.9 | Palliative (P) | 2019-09-21 | 2019-09-24 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100164717 |
| 20219290 | 20178437 | 1.66 | 59.2 | Palliative (P) | 2017-05-28 | 2017-06-19 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101059105 |
| 20219322 | 20178439 | 1.74 | 99.7 | Palliative (P) | 2019-11-13 | 2021-09-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101850825 |
| 20219337 | 20178440 | 1.71 | 87 | Palliative (P) | null | 2021-06-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100572151 |
| 20219368 | 20178441 | 1.71 | 60 | Palliative (P) | 2016-09-13 | 2019-10-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100323023 |
| 20219389 | 20178442 | 1.72 | 100 | Palliative (P) | 2016-05-17 | 2016-05-17 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100561204 |
| 20219400 | 20178443 | 1.82 | 82 | Palliative (P) | 2021-05-19 | 2022-02-14 | GEMCITABINE + Paclitaxel Albumin | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101628008 |
| 20219416 | 20178444 | 0 | 81.3 | Curative (C) | 2017-11-28 | 2017-12-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101466062 |
| 20219485 | 20178445 | 1.78 | 91.8 | null | 2020-03-23 | 2020-04-08 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101147109 |
| 20219493 | 20178446 | 1.74 | 109.5 | Palliative (P) | 2018-03-30 | 2018-10-11 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100051411 |
| 20219516 | 20178447 | 1.68 | 99.1 | Palliative (P) | 2018-06-20 | 2018-06-28 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100562788 |
| 20219535 | 20178448 | 1.74 | 75.1 | 02 | 2016-06-18 | 2016-07-09 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100715724 |
| 20219572 | 20178449 | 1.77 | 50.2 | Palliative (P) | 2017-02-26 | 2017-02-27 | GEMCITABINE + Paclitaxel Albumin | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101645648 |
| 20219584 | 20178450 | 1.56 | 82.4 | null | 2016-08-05 | 2016-09-04 | GEMCITABINE + Paclitaxel Albumin | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100714248 |
| 20219600 | 20178451 | 1.8 | 87.8 | Neo-adjuvant (N) | 2016-12-11 | 2017-01-15 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100865750 |
| 20219645 | 20178452 | 1.65 | 47 | Palliative (P) | 2018-12-29 | 2018-12-29 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100984056 |
| 20219709 | 20178453 | 1.81 | 89 | null | 2019-11-08 | 2020-04-28 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101866397 |
| 20219732 | 20178454 | 1.74 | 78 | Palliative (P) | 2019-04-24 | 2019-05-15 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101424888 |
| 20219865 | 20178455 | 1.76 | 40.4 | null | 2019-10-31 | 2019-11-08 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100037819 |
| 20219889 | 20178456 | 1.58 | 59.2 | Palliative (P) | 2018-01-30 | 2018-02-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100176802 |
| 20219912 | 20178458 | 1.7 | 72 | null | null | 2019-05-02 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100171984 |
| 20219994 | 20178459 | 1.7 | 82.2 | Palliative (P) | null | 2019-01-07 | ECX | 02 | N | ECX | 101056989 |
| 20220065 | 20178460 | 1.75 | 52 | null | 2019-02-20 | 2019-03-04 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100503704 |
| 20220070 | 20178461 | null | 86 | null | null | 2021-07-29 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101607846 |
| 20220091 | 20178462 | 1.63 | 63.5 | Palliative (P) | null | 2021-11-11 | null | 2 | N | CARBOPLATIN + ETOPOSIDE | 100566479 |
| 20220163 | 20178463 | 1.76 | 46.7 | null | null | 2019-11-08 | CARBOPLATIN + ETOPOSIDE | null | null | ECX | 101768239 |
| 20220173 | 20178464 | 1.64 | 57.8 | null | 2017-05-14 | 2017-05-14 | null | 02 | null | ECX | 100927755 |
| 20220179 | 20178465 | null | 85.05 | null | 2017-08-16 | 2018-01-13 | null | 2 | null | ECX | 101150997 |
| 20220243 | 20178466 | 1.75 | null | null | 2016-04-01 | 2016-07-27 | null | 02 | N | NIVOLUMAB | 100340220 |
| 20220299 | 20178467 | 1.78 | 71 | Palliative (P) | 2019-03-12 | 2019-06-02 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100788704 |
| 20220344 | 20178470 | 1.76 | 97.5 | Palliative (P) | 2016-11-20 | 2016-11-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101285395 |
| 20220352 | 20178471 | 1.54 | 83.8 | Palliative (P) | 2018-08-11 | 2018-08-13 | null | 2 | N | ECX | 101225375 |
| 20220397 | 20178472 | 1.75 | 77 | null | 2016-12-29 | 2017-02-02 | null | 02 | N | ECX | 100387687 |
| 20220591 | 20178473 | null | null | null | 2017-11-17 | 2017-11-18 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101738612 |
| 20220604 | 20178474 | 1.79 | null | null | 2017-06-10 | 2017-06-18 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100280549 |
| 20220689 | 20178476 | 1.61 | 97.6 | null | 2016-02-27 | 2016-03-16 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 100739337 |
| 20220714 | 20178477 | 1.87 | 57.1 | Palliative (P) | 2020-10-03 | 2020-10-23 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 101248078 |
| 20220745 | 20178478 | 1.59 | 81 | Neo-adjuvant (N) | 2019-03-24 | 2019-03-31 | null | 02 | N | ECX | 100231340 |
| 20220778 | 20178480 | 1.7 | 61.4 | null | 2018-04-23 | 2018-09-10 | Cisplatin + Modified de Gramont | 02 | null | CISPLATIN + FLUOROURACIL | 100854304 |